Ralph Schiess
Vorstandsvorsitzender bei ONCONETIX, INC.
Vermögen: 32 370 $ am 30.04.2024
Profil
Ralph Schiess is the founder and Chief Executive Officer of Proteomedix AG, a company founded in 2010.
He is currently the Chief Executive & Science Officer at Onconetix, Inc., a position he started in 2023.
Dr. Schiess has a graduate degree from the University of Zurich and a doctorate degree from the Swiss Federal Institute of Technology.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
ONCONETIX INC
1,21% | 05.04.2024 | 269 749 ( 1,21% ) | 32 370 $ | 30.04.2024 |
Aktive Positionen von Ralph Schiess
Unternehmen | Position | Beginn |
---|---|---|
ONCONETIX, INC. | Vorstandsvorsitzender | 12.01.2024 |
ProteoMediX AG
ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Vorstandsvorsitzender | 01.01.2010 |
Ausbildung von Ralph Schiess
University of Zurich | Graduate Degree |
Swiss Federal Institute of Technology | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ONCONETIX, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
ProteoMediX AG
ProteoMediX AG BiotechnologyHealth Technology ProteoMediX AG operates in the identification of novel biomarkers for the early detection of cancer and the personalized treatment. The firm products include Prostate cancer detection, stratification and prognosis. The company was founded by Ralph Schiess, Christian Br?hlmann and Wilhelm Krek in 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |